• Produktinformation
  • Downloads



An Inside Out Approach to Prostate Ablation

Profound Medical is a Canadian medical device company that has developed a unique and minimally invasive procedure to ablate targeted prostate tissue.

Profound’s novel technology, TULSA, combines real-time MR imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. It provides a highly precise treatment tailored to patient-specific anatomy and pathology. This method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery.

12-month results of the TULSA-PROTM Phase 1 Clinical Trial published in European Urology (http://bit.ly/1O7LVcv) demonstrated clinical safety and precision of TULSA-PRO for near whole-gland prostate ablation, with low toxicity and a well-tolerated safety profile. Profound Medical continues to monitor the initial 30 patients for 5 years.

A 110 patient Pivotal Trial is being established in over 10 institutions in Europe (Germany, Spain, The Netherlands), Canada and the United States.

Technische Spezifikationen

Fragen zum Produkt

Kontakt Medical Systems

Standort Gallspach
Spitzermühlestraße 6
A - 4713 Gallspach
+43 1 80104 - 2801
Google Maps Location

Technische Service-Hotline
+43 1 801 04 – 2587

Mo – Do von 7:00 bis 16:00
Fr von 8:00 bis 12:30